Progression of vertebral fractures despite long-term biochemical control of acromegaly: a prospective follow-up study.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Journal of Clinical Endocrinology and Metabolism

• Publication date

  2013-09-30

• Fields of study

  Medicine

• Identifiers
  DOI 10.1210/jc.2013-2695PMID 24081732
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Vertebral fractures in patients with acromegaly: a 3-year prospective study.

  2013cited by this paper
• Vertebral fracture assessment in acromegaly.

  2013cited by this paper
• Vertebral fracture assessment in acromegaly.

  2013cited by this paper
• Microindentation can discriminate between damaged and intact human bone tissue.

  2012cited by this paper
• High prevalence of vertebral fractures despite normal bone mineral density in patients with long-term controlled acromegaly.

  2011influential reference
• Clinical osteoarthritis predicts physical and psychological QoL in acromegaly patients.

  2010cited by this paper
• Spine radiographs to improve the identification of women at high risk for fractures

  2009cited by this paper
• High prevalence of arthropathy, according to the definitions of radiological and clinical osteoarthritis, in patients with long-term cure of acromegaly: a case-control study.

  2009cited by this paper
• Testosterone, bone and osteoporosis.

  2009cited by this paper
• Spinal volumetric trabecular bone mass in acromegalic patients: a longitudinal study

  2009cited by this paper
• Growth hormone, insulin-like growth factors, and the skeleton.

  2008cited by this paper
• Prevalence of vertebral fractures in men with acromegaly.

  2008cited by this paper
• Mortality in acromegaly: a metaanalysis.

  2008cited by this paper
• Mechanisms of anabolic therapies for osteoporosis.

  2007cited by this paper
• Risk of fracture in women with type 2 diabetes: the Women's Health Initiative Observational Study.

  2006cited by this paper
• Increased Prevalence of Radiological Spinal Deformities in Active Acromegaly: A Cross‐Sectional Study in Postmenopausal Women

  2005cited by this paper
• Bone mineral density and turnover in patients with acromegaly in relation to sex, disease activity, and gonadal function

  2005cited by this paper
• Long-term maintenance of the anabolic effects of GH on the skeleton in successfully treated patients with acromegaly.

  2005cited by this paper
• Morbidity after long-term remission for acromegaly: persisting joint-related complaints cause reduced quality of life.

  2005cited by this paper
• Systemic complications of acromegaly: epidemiology, pathogenesis, and management.

  2004cited by this paper
• Determinants of survival in treated acromegaly in a single center: predictive value of serial insulin-like growth factor I measurements.

  2004cited by this paper
• Bone density threshold and other predictors of vertebral fracture in patients receiving oral glucocorticoid therapy.

  2003cited by this paper
• Bone mineral density in acromegaly: the effect of gender, disease activity and gonadal status

  2003cited by this paper
• Growth hormone in glucocorticoid-induced osteoporosis.

  2002cited by this paper
• Decreased trabecular bone biomechanical competence, apparent density, IGF‐II and IGFBP‐5 content in acromegaly

  2002cited by this paper
• Patients with Prior Fractures Have an Increased Risk of Future Fractures: A Summary of the Literature and Statistical Synthesis

  2000cited by this paper
• Ten-year follow-up results of transsphenoidal microsurgery in acromegaly.

  2000cited by this paper
• Vertebral Fracture Definition from Population-Based Data: Preliminary Results from the Canadian Multicenter Osteoporosis Study (CaMos)

  2000cited by this paper
• Association of prevalent vertebral fractures, bone density, and alendronate treatment with incident vertebral fractures: effect of number and spinal location of fractures. The Fracture Intervention Trial Research Group.

  1999cited by this paper
• Prevalent Vertebral Deformities Predict Hip Fractures and New Vertebral Deformities but Not Wrist Fractures

  1999cited by this paper
• Gonadal status is an important determinant of bone density in acromegaly

  1998cited by this paper
• Growth hormone and bone.

  1998cited by this paper
• Plasma Levels of Insulin-Like Growth Factor (IGF)-I, IGF-II and IGF-Binding Protein-3 in the Evaluation of Childhood Growth Hormone Deficiency

  1998cited by this paper
• Role of growth hormone and sex steroids in achieving and maintaining normal bone mass.

  1996cited by this paper
• Bone Loss and Bone Turnover in Diabetes

  1995cited by this paper
• Vertebral fracture assessment using a semiquantitative technique

  1993cited by this paper
• Pre-existing fractures and bone mass predict vertebral fracture incidence in women.

  1991cited by this paper
• The LMS method for constructing normalized growth standards.

  1990cited by this paper
• Differential effects of endocrine dysfunction on the axial and the appendicular skeleton.

  1982influential reference

• Intervertebral disc degeneration is accelerated by GH overexpression but attenuated by GH antagonism.

  2025cites this paper
• Acromegaly treatment and bone: a bidirectional relationship

  2025cites this paper
• Bone Health in Acromegaly.

  2025cites this paper
• Growth hormone and bone: pre-clinical and clinical perspectives.

  2025cites this paper
• Early Predictors of Remission in Acromegaly Patients after Pure Endoscopic Endonasal Transsphenoidal Surgery

  2024cites this paper
• Impact of medical therapy for hormone-secreting Pituitary tumors on bone

  2024cites this paper
• Long-term Pegvisomant Therapy of Acromegaly: Effects on Bone Density, Turnover and Microstructure Using HRpQCT

  2024cites this paper
• Sclerostin and OPG/RANK-L system take part in bone remodeling in patients with acromegaly

  2024cites this paper
• Growth hormone secretion disorders and their impact on bone quality

  2024cites this paper
• Conventional X-rays in the diagnosis and follow-up of vertebral fractures in patients with acromegaly: a real-life study

  2023cites this paper
• Osteosarcopenia in acromegaly: reduced muscle quality and increased vertebral fat deposition

  2023cites this paper
• Exosomal RNAs in the development and treatment of pituitary adenomas

  2023cites this paper
• Increased Risk of Hip Fracture in Patients with Acromegaly: A Nationwide Cohort Study in Korea

  2023cites this paper
• Differences between bone health parameters in adults with acromegaly and growth hormone deficiency: A systematic review.

  2023cites this paper
• Persistent Deficits in Bone Quality in Treated Acromegaly: Evidence From Assessments of Microstructure

  2023cites this paper
• Skeletal complications in acromegaly

  2023cites this paper
• Endocortical Trabecularization in Acromegaly: The Cause for the Paradoxically Increased Vertebral Fracture Risk?

  2023cites this paper
• Musculoskeletal Effects of Altered GH Action

  2022cites this paper
• Direct effects of octreotide on osteoblast cell proliferation and function

  2022cites this paper
• Acromegaly

  2022cites this paper
• Looking at the spine in controlled Acromegaly

  2022cites this paper
• Acromegaly: pathogenesis, diagnosis, and management.

  2022cites this paper
• Evaluating the Impact of Acromegaly on Quality of Life.

  2022cites this paper
• Impact of the diagnostic delay of acromegaly on bone health: data from a real life and long term follow-up experience

  2022cites this paper
• Determinants of skeletal fragility in acromegaly: a systematic review and meta-analysis

  2022cites this paper
• Clinical and radiographic assessment of peripheral joints in controlled acromegaly

  2022cites this paper
• High Prevalence of Vertebral Fractures Associated with Preoperative GH Levels in Patients with recent Diagnosis of Acromegaly.

  2022cites this paper
• Update on vertebral fractures in pituitary diseases: from research to clinical practice

  2021cites this paper
• Ostéopathies fragilisantes endocriniennes

  2021cites this paper
• Гормональная регуляция остеогенеза

  2021cites this paper
• Osteopatías fragilizantes endocrinas

  2021cites this paper
• The Negative Impacts of Acromegaly on Bone Microstructure Not Fully Reversible

  2021cites this paper
• Low sclerostin levels after long-term remission of acromegaly

  2021cites this paper
• Vertebral fractures occur despite control of acromegaly and are predicted by cortical volumetric bone mineral density.

  2021cites this paper
• Spine Bone Texture Assessed by Trabecular Bone Score in Active and Controlled Acromegaly: A Prospective Study

  2021influential citation
• Osteoporosis and arthropathy in functioning pituitary tumors

  2021cites this paper
• Prevalence of vertebral fractures and serum sclerostin levels in acromegaly

  2021influential citation
• L’acromégalie est associée à des déformations vertébrales mais pas à des fractures vertébrales : étude monocentrique transversale

  2021cites this paper
• Trabecular bone score and bone mineral density in patients with long‐term controlled acromegaly

  2021cites this paper
• MANAGEMENT OF ENDOCRINE DISEASE: Does gender matter in the management of acromegaly.

  2020cites this paper
• A Consensus on the Diagnosis and Treatment of Acromegaly Comorbidities: An Update.

  2020cites this paper
• Effects of Pegvisomant and Pasireotide LAR on vertebral fractures in acromegaly resistant to First-Generation SRLs.

  2020cites this paper
• Osteopatia acromegalica: diagnosi e trattamento

  2020cites this paper
• Acromegaly and Vertebral Fractures: Facts and Questions.

  2020cites this paper
• Acromegaly in the elderly patients

  2020cites this paper
• Rheumatic manifestations of acromegaly

  2020cites this paper
• Acromegaly is associated with vertebral deformations but not vertebral fractures: results of a cross-sectional monocentric study.

  2020cites this paper
• Treatment of Acromegalic Osteopathy in Real-Life Clinical Practice: The BAAC (Bone Active drugs in ACromegaly) Study.

  2020cites this paper
• Progression of vertebral fractures in long-term controlled acromegaly: a 9-year follow-up study.

  2020cites this paper
• Acromegaly: Update on Management and Long-Term Morbidities.

  2020cites this paper
• Bone densitometry by Radiofrequency Echographic Multi-Spectrometry (REMS) in acromegaly patients.

  2020cites this paper
• Vertebral Fractures Associated with Spinal Sagittal Imbalance and Quality of Life in Acromegaly: A Radiographic Study with EOS 2D/3D Technology

  2020cites this paper
• Progression of acromegalic arthropathy in long-term controlled acromegaly patients: 9 years of longitudinal follow-up.

  2020cites this paper
• Faculty Opinions recommendation of MANAGEMENT OF ENDOCRINE DISEASE: Does gender matter in the management of acromegaly?

  2020cites this paper
• Pathophysiology of growth hormone secretion disorders and their impact on bone microstructure as measured by trabecular bone score.

  2019cites this paper
• MANAGEMENT OF ENDOCRINE DISEASE: Bone disorders associated with acromegaly: mechanisms and treatment.

  2019cites this paper
• Hip Structure Analyses in Acromegaly: Decrease of Cortical Bone Thickness After Treatment: A Longitudinal Cohort Study

  2019influential citation
• Determinants of morbidities and mortality in acromegaly

  2019cites this paper
• The acromegalic spine: fractures, deformities and spinopelvic balance

  2019cites this paper
• Non-invasive DXA-derived bone structure assessment of acromegaly patients: a cross-sectional study.

  2019cites this paper
• Association between biochemical control and comorbidities in patients with acromegaly: an Italian longitudinal retrospective chart review study

  2019cites this paper
• Exosomal hsa-miR-21-5p derived from growth hormone-secreting pituitary adenoma promotes abnormal bone formation in acromegaly.

  2019cites this paper
• Other Secondary Causes of Osteoporosis

  2018cites this paper
• Acromegalic osteopathy: An update

  2018cites this paper
• Pituitary Diseases and Bone

  2018cites this paper
• THE COMPREHENSIVE IMPACT ON HUMAN BODY INDUCED BY WITHDRAWAL OF GROWTH HORMONE EXCESS Supplemental Methods

  2018cites this paper
• Bone and joint structural impairments in acromegaly

  2018influential citation
• The comprehensive impact on human body induced by resolution of growth hormone excess.

  2018cites this paper
• Bone histomorphometry in acromegaly patients with fragility vertebral fractures

  2018cites this paper
• [Bone quality in patients with acromegaly].

  2018cites this paper
• Correction to: Effects of pegvisomant and somatostatin receptor ligands on incidence of vertebral fractures in patients with acromegaly

  2018cites this paper
• GH/IGF-I and Bone

  2018cites this paper
• Neuroendocrinology of Bone Metabolism

  2018cites this paper
• A Consensus Statement on acromegaly therapeutic outcomes

  2018cites this paper
• Systemic Complications of Acromegaly and the Impact of the Current Treatment Landscape: An Update.

  2018cites this paper
• Multidisciplinary Approach to Osteoporosis

  2018cites this paper
• Calcium and Bone Turnover Markers in Acromegaly: A Prospective, Controlled Study

  2017cites this paper
• Effects of pegvisomant and somatostatin receptor ligands on incidence of vertebral fractures in patients with acromegaly

  2017cites this paper
• Bone material strength index as measured by impact microindentation is altered in patients with acromegaly.

  2017cites this paper
• Acromegalic osteopathy

  2016influential citation
• Skeletal effects of growth hormone and insulin-like growth factor-I therapy.

  2016cites this paper
• Understanding the effect of acromegaly on the human skeleton

  2016cites this paper
• T2 weighted MRI and Histopathology as Markers for Response to Somatostatin Analogues in Acromegaly

  2016cites this paper
• [Acromegaly and Cushing's disease: Persistence of comorbidities after the control of hypersecretion].

  2016cites this paper
• High-resolution-cone beam tomography analysis of bone microarchitecture in patients with acromegaly and radiological vertebral fractures

  2016cites this paper
• The chronic syndromes after previous treatment of pituitary tumours

  2016cites this paper
• Fractures in pituitary adenoma patients from the Dutch National Registry of Growth Hormone Treatment in Adults

  2016influential citation
• The risks of overlooking the diagnosis of secreting pituitary adenomas

  2016cites this paper
• Treatment of acromegaly increases BMD but reduces trabecular bone score: a longitudinal study.

  2016cites this paper
• Pituitary diseases and bone.

  2015cites this paper
• Diagnosis, treatment and clinical perspectives of acromegaly

  2015cites this paper
• Reduction of trabecular and cortical volumetric bone mineral density at the proximal femur in patients with acromegaly.

  2015cites this paper
• Outcome of complications in acromegaly patients after long-term disease remission

  2015cites this paper
• Low Prevalence of Periodontitis in Acromegaly: Growth Hormone May Exert a Protective Effect

  2015cites this paper
• Excessive growth hormone expression in male GH transgenic mice adversely alters bone architecture and mechanical strength.

  2015cites this paper
• Bone turnover, bone mineral density, and fracture risk in acromegaly: a meta-analysis.

  2015influential citation
• Part B The role of the GH / IGF-1 axis in primary OA

  2015cites this paper
• Bone and Joint Disorders in Acromegaly

  2015cites this paper
• [Update of recommendations for evaluation and treatment of osteoporosis associated to endocrine and nutritional conditions. Working Group on Osteoporosis and Mineral Metabolism of the Spanish Society of Endocrinology].

  2015cites this paper
• Postoperative changes in bone metabolism and bone mineral density in Japanese patients with acromegaly: a 3-year prospective study.

  2015cites this paper